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Methods: ER and AMR were compared in patients undergoing percutaneous RF ablation for AFib. ER was defined by right and left appendage activation rate (RAAAR and LAAAR) as a surrogate for atrial refractory periods. AMR was approached by left atrium (LA) diameters and area and left atrial appendage (LAA) area and contractile function (mean emptying flow velocity) (LAAFV) as determined during transoesophageal and transthoracic echocardiography performed during AFib the day before or immediately before RF ablation. Mean duration between successive LAA contractions was considered as LAA mechanical rate.
Results: 40 pts with paroxysmal AFib (n=10), persistent AFib (n=25) or long-persistent AFib (n=5) were included (30 men, 64±9 yo, EF 39±14%). 63% were on amiodarone.
Parameters exploring AMR were highly correlated to each other: LA area 27±7 cm 2 ; LAA area 5.5±2 cm 2 ; LA transv 48±14 mm ; LA ant-post 58±13 mm ; LAA velocity 28±13 cm/sec (p<0,05 for each comparison).
Parameters exploring ER were also highly correlated: RAAAR 180± 39 msec; LAAAR 175±34 msec (p<0,0001). There was no significant correlation between any ER and AR parameter.
Only LAA mechanical rate (172±36 msec) was highly correlated the LAAAR (p<0,01).
Conclusion:
ER and AMR are not mutually related, atrial activation rate being not correlated to LA or LAA size and mechanical function. Thus, the mechanisms leading to AFib induced atrial remodeling may differ for anatomical-mechanical and electrophysiological aspects. Supraventricular reentrant tachycardia (SVT) can be due to atrioventricular node reentrant tachycardia (AVNRT) or atrioventricular reentrant tachycardia (AVRT) in a concealed or an overt accessory pathway (AP) in patients with a Wolff-Parkinson-White syndrome (WPW). The purpose of the study was to look for the mode of SVT induction and to correlate the mode of induction with the mechanism of the tachycardia.
Methods: 1818 patients were consecutively referred for a SVT. 438 had a WPW (group I). Remaining patients had a normal ECG. At electrophysiological study (EPS), SVT was related to AVRT in 251 patients (group II), to typical AVNRT in 969 patients (group II) and to atypical AVNRT in 160 patients (group IV). Atrial pacing and programmed atrial stimulation with one and 2 extrastimuli were performed in control state (CS). If SVT was not induced, the protocol was repeated after isoproterenol (0.02 to 1 µg. min -1 ) infused to increase sinus rate to at least 130 bpm.
Results:
Groups differed by age and gender: group I was younger than group II (36±17 vs 42±17 years) (p< 0.001). Group II was younger than group III (49±19)(p <0.001) and group III was younger than group IV (55±19) (p< 0.001). Gender in group I and II was more frequently male (55%, 57%) than in group III (36%) and IV (36%)(p<0.000). SVT induction required more frequently isoproterenol infusion among patients of group III with a typical AVNRT (32%) and IV with atypical AVNRT (33%) than in patients of group I (26%)(p<0.05) or group II (24%) (p< 0.02). Men required more frequently isoproterenol than women only in group I (p<0.0001). The youngest patients required more frequently isoproterenol than other but the differences were only significant in group III (47±19 vs 51±9 years, p<0.005).
Conclusions:
Isoproterenol infusion is more frequently required in patients with typical or atypical AVNRT than in patients with AVRT using an overt or a concealed AP. The youngest patients with AVNRT required isoproterenol infusion for the SVT induction more frequently than adults. Isoproterenol is required more frequently in men than in women only in patients with a WPW syndrome. 
